Tty Biopharm

TTY Biopharm's Carbon Emissions & Climate Commitments (TW)

TTY Biopharm, a Pharmaceutical Preparation Manufacturing company based in Taiwan, reported its total greenhouse gas emissions for 2024 as approximately 12.54 million kg CO2e. This figure includes:

• Scope 1 emissions: Approximately 1.91 million kg CO2e
• Scope 2 emissions: Approximately 8.12 million kg CO2e
• Scope 3 emissions: Approximately 2.51 million kg CO2e

In 2023, the company's total emissions were approximately 12.74 million kg CO2e, comprising about 1.70 million kg CO2e (Scope 1), 8.49 million kg CO2e (Scope 2), and 2.55 million kg CO2e (Scope 3). This represents a slight decrease in overall emissions between 2023 and 2024.

Looking further back, TTY Biopharm's total emissions were approximately 12.81 million kg CO2e in 2022. For 2021, Scope 1 emissions were around 925,000 kg CO2e and Scope 2 emissions were approximately 6.98 million kg CO2e; Scope 3 data was not disclosed for that year. In 2020, Scope 1 emissions were approximately 953,000 kg CO2e and Scope 2 emissions were around 7.74 million kg CO2e. For 2019, Scope 1 emissions were about 977,000 kg CO2e and Scope 2 emissions were approximately 7.24 million kg CO2e.

In 2018, the company reported Scope 1 emissions of approximately 7.78 million kg CO2e and Scope 2 emissions of about 7.78 million kg CO2e. In 2017, TTY Biopharm's total emissions were approximately 8.26 million kg CO2e, with Scope 1 at about 756,000 kg CO2e and Scope 2 at approximately 4.23 million kg CO2e. For 2016, the total reported emissions were approximately 8.07 million kg CO2e, which included Scope 3 emissions (purchased goods and services) of about 625,000 kg CO2e; Scope 1 and 2 data was not disclosed for that year. In 2015, Scope 1 emissions were around 625,000 kg CO2e and Scope 2 emissions were approximately 3.63 million kg CO2e.

TTY Biopharm has not publicly disclosed specific quantifiable reduction targets, Science-Based Targets (SBTi) or a Climate Pledge. The emissions data is reported directly by TTY Biopharm Company Limited and is not cascaded from a parent organisation.